Investor Presentation Q1 2023
141
Investor presentation
First three months of 2023
Attractive capital allocation to shareholders
DKK billion
60
50
Annual cash return to shareholders
10
40
40
8
18
8
50
16
30
14
13
20
20
10
20
17
20
0
2020
Capital allocation
Novo NordiskⓇ
• The proposed final dividend of 8.15 DKK per share, in addition to the
interim dividend of 4.25 DKK per share, corresponds to full year
dividend of 12.40 DKK per share in 2022
• Total dividend per share increasing 19% in 2022
• Total capital allocation for 2022 of 49 bDKK to shareholders between
share buy back and dividend
28
24
• For 2023, we expect to initiate a new 12-month share repurchase
programme of up to DKK 30 billion
2021
2022
Dividend
Interim Dividend
2023E
Share Repurchase
Note: Share repurchase programmes run for 12 months starting in February. The total programme may be reduced in size if significant business development opportunities arise during 2023. The 2023E interim dividend included for illustrative purposes.View entire presentation